Royal Bank Of Canada Kronos Bio, Inc. Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.73 - $1.38 $144 - $273	198 Added 180.0%	308 $0
Q1 2024 Nov 05, 2024	SELL	$1.02 - $1.3 $201 - $257	-198 Reduced 64.29%	110 $0
Q1 2024 May 15, 2024	SELL	$1.02 - $1.3 $103 - $131	-101 Reduced 47.87%	110 $0
Q4 2023 Feb 14, 2024	SELL	$0.75 - $1.49 $4,727 - $9,391	-6,303 Reduced 96.76%	211 $0
Q3 2023 Nov 14, 2023	BUY	$1.23 - $2.25 $8,012 - $14,656	6,514 New	6,514 $8,000
Q1 2023 May 15, 2023	SELL	$1.34 - $2.62 $4,623 - $9,039	-3,450 Reduced 59.99%	2,301 $3,000
Q4 2022 Feb 14, 2023	SELL	$1.44 - $3.44 $7,236 - $17,286	-5,025 Reduced 46.63%	5,751 $9,000
Q3 2022 Nov 14, 2022	BUY	$3.35 - $5.55 $891 - $1,476	266 Added 2.53%	10,776 $36,000
Q2 2022 Aug 15, 2022	SELL	$3.12 - $7.52 $6,726 - $16,213	-2,156 Reduced 17.02%	10,510 $38,000
Q1 2022 May 16, 2022	SELL	$6.26 - $14.42 $31,969 - $73,642	-5,107 Reduced 28.73%	12,666 $91,000
Q4 2021 Feb 14, 2022	BUY	$11.35 - $21.18 $138,878 - $259,158	12,236 Added 220.99%	17,773 $242,000
Q3 2021 Nov 15, 2021	BUY	$18.17 - $24.7 $34,141 - $46,411	1,879 Added 51.37%	5,537 $116,000
Q2 2021 Aug 16, 2021	BUY	$20.08 - $29.02 $73,452 - $106,155	3,658 New	3,658 $88,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.